美国幕上肿瘤切除伴与不伴手术显微镜使用的费用与并发症
基于美国全国行政数据库的回顾性分析,纳入2007至2016年接受幕上切除的12058例胶质瘤和5433例脑转移患者,比较使用与不使用手术显微镜者的30天并发症、再入院和费用。显微镜使用率各州从19.0%至68.6%不等,与胶质瘤患者住院费用增加5228.90美元、转移瘤患者增加2824.00美元相关(P<0.001),术中脑水肿发生率较低(P<0.027),30天神经系统并发症略低(14.7% vs 16.7%,P=0.048),其他并发症、再入院及30天术后费用无差异。
要点
- 显微镜使用率各州从19.0%至68.6%不等。
- 显微镜使用与胶质瘤住院费用增加5228.90美元、转移瘤增加2824.00美元相关(P<0.001)。
- 显微镜组30天神经系统并发症14.7% vs 非显微镜组16.7%(P=0.048)。
核心结论
- 幕上切除使用手术显微镜因州而异,并与更高的手术费用相关;显微镜使用可能与较低的术中脑水肿及部分脑血管并发症发生率相关,但与其他并发症、再入院或30天费用无显著差异。
研究设计与样本
- 回顾性分析,使用全国行政数据库识别2007至2016年间接受幕上切除的胶质瘤或脑转移患者。
- 队列包括12058例胶质瘤患者和5433例转移瘤患者。
- 采用单变量和多变量分析评估使用与不使用显微镜患者的30天并发症、再入院和费用。
主要发现
- 显微镜使用率各州从19.0%至68.6%不等。
- 显微镜使用与胶质瘤患者住院费用增加5228.90美元相关(P<0.001),与转移瘤患者增加2824.00美元相关(P<0.001)。
- 显微镜组术中脑水肿发生率低于非显微镜组(P<0.027)。
- 显微镜使用与30天神经系统并发症略低相关(14.7% vs 16.7%,P=0.048),具体为非特异性脑血管并发症。
- 其他并发症发生率、再入院率或30天术后费用无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The operative microscope, a commonly used tool in neurosurgery, is critical in many supratentorial tumor cases. However, use of operating microscope for supratentorial tumor varies by surgeon. OBJECTIVES: To assess complication rates, readmissions, and costs associated with operative microscope use in supratentorial resections. METHODS: A retrospective analysis was conducted using a national administrative database to identify patients with glioma or brain metastases who underwent supratentorial resection between 2007 and 2016. Univariate and multivariate analyses were used to assess 30-day complications, readmissions, and costs between patients who underwent resection with and without use of microscope. RESULTS: The cohort included 12,058 glioma patients and 5433 metastasis patients. Rates of microscope use varied by state from 19.0% to 68.6%. Microscope use was associated with $5228.90 in additional costs of index hospitalization among glioma patients (P <0.001), and $2824.00 among metastasis patients (P <0.001). Rates of intraoperative cerebral edema were lower among the microscope cohort than among the nonmicroscope cohort (P <0.027). Microscope use was associated with a slight reduction in 30-day rates of neurological complications (14.7% vs. 16.7%, P = 0.048), specifically in nonspecific cerebrovascular complications. There were no differences in rates of other complications, readmissions, or 30-day postoperative costs. CONCLUSIONS: Use of operative microscope for supratentorial resections varies by state and is associated with higher cost of surgery. Microscope use may be associated with lower rates of intraoperative cerebral edema and some cerebrovascular complications, but is not associated with significant differences in other complications, readmissions, or 30-day costs.
引用
- Zhang Y, Zhang M, Lin M, et al. Costs and Complications Associated With Resection of Supratentorial Tumors With and Without the Operative Microscope in the United States. World Neurosurg. 2020. PMID: 32171932. doi:10.1016/j.wneu.2020.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。